Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-03

Clinical Trial Update: Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic Fibrosis [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial assessing non-pulmonary contributors to exercise intolerance in cystic fibrosis has completed. The study was sponsored by Virgin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Cystic Fibrosis | EARLY_Phase 1 | Status: COMPLETED